Bristol-Myers CEO talks new acquisitions: ‘We are writing the next chapter of this company’
[ad_1] Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s…
2024-07-08 15:22:37
[ad_1] Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s…
[ad_1] CNBC’s Jim Cramer applauded Monday’s market gains for Big Tech, which had seen a sell-off in the early days…
[ad_1] CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving…
[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin…
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services…
[ad_1] Check out the companies making headlines in midday trading. Intel — The semiconductor stock added 4.6% after Israel’s government…
[ad_1] Check out the companies making headlines before the bell. Intel — The semiconductor stock climbed 2.2% on news that…
[ad_1] Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near…
[ad_1] Check out the companies making headlines in midday trading. Nike , Foot Locker — Shares of Nike plummeted 10%…
[ad_1] Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash,…